A Phase II , Placebo-controlled Study to Assess Efficacy of 28 Day Oral AZD9668 in Patients With Cystic Fibrosis

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2009

Conditions

Cystic Fibrosis

Interventions

DRUG

AZD9668

60 mg, oral tablet, twice daily for 28 days

DRUG

AZD9668 Placebo equivalent

Match placebo to 60 mg, oral tablet, twice daily for 28 days

Trial Locations (14)

Research Site, Copenhagen

Research Site, Hamburg

Research Site, Kiel

Research Site, Leipzig

Research Site, München

Research Site, Rabka-Zdrój

Research Site, Warsaw

Research Site, Moscow

Research Site, Gothenburg

Research Site, Lund

Research Site, Stockholm

Research Site, Uppsala

Research Site, Belfast

Research Site, Liverpool